A detailed history of First Horizon Advisors, Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 10 shares of BHC stock, worth $94. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 10 -0.0%
Holding current value
$94
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

SELL
$7.69 - $9.71 $23,070 - $29,130
-3,000 Reduced 99.67%
10 $0
Q3 2022

Nov 09, 2022

SELL
$4.58 - $9.21 $11,894 - $23,918
-2,597 Reduced 46.32%
3,010 $21,000
Q2 2022

Aug 02, 2022

BUY
$7.06 - $23.63 $18,200 - $60,918
2,578 Added 85.11%
5,607 $46,000
Q1 2022

May 10, 2022

SELL
$21.6 - $27.79 $44,366 - $57,080
-2,054 Reduced 40.41%
3,029 $70,000
Q4 2021

Feb 09, 2022

SELL
$23.0 - $29.01 $7,912 - $9,979
-344 Reduced 6.34%
5,083 $140,000
Q3 2021

Nov 15, 2021

BUY
$25.04 - $30.06 $56,865 - $68,266
2,271 Added 71.96%
5,427 $151,000
Q3 2021

Nov 09, 2021

SELL
$25.04 - $30.06 $56,615 - $67,965
-2,261 Reduced 41.74%
3,156 $87,000
Q4 2020

Feb 11, 2021

BUY
$15.31 - $21.12 $6,904 - $9,525
451 Added 9.08%
5,417 $112,000
Q3 2020

Nov 12, 2020

BUY
$14.88 - $20.13 $5,163 - $6,985
347 Added 7.51%
4,966 $77,000
Q2 2020

Jul 31, 2020

BUY
$13.31 - $20.51 $8,198 - $12,634
616 Added 15.39%
4,619 $84,000
Q1 2020

May 05, 2020

BUY
$12.98 - $30.25 $2,349 - $5,475
181 Added 4.74%
4,003 $62,000
Q4 2019

Jan 07, 2020

BUY
$18.89 - $31.89 $72,197 - $121,883
3,822 New
3,822 $114,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $3.41B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.